PUNITHA RATHNAM: Open Payments
NPI 1558564005 · GOLDSBORO, NC. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,905 in 72 payments from 16 companies in 2025. Trend: 2023 $903 · 2024 $830 · 2025 $1,905
Food & beverage: $1,089Travel & lodging: $705Education: $111
| Company | Payments | Amount |
|---|---|---|
| Brainsway USA INC | 1 | $705 |
| ABBVIE INC. | 15 | $227 |
| Vanda Pharmaceuticals Inc. | 17 | $222 |
| Teva Pharmaceuticals USA, Inc. | 8 | $200 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 6 | $107 |
| Neurocrine BioSciences, Inc. | 6 | $104 |
| Otsuka America Pharmaceutical, Inc. | 6 | $102 |
| Tris Pharma Inc | 3 | $56 |
| Alkermes, Inc. | 2 | $34 |
| Janssen Pharmaceuticals, Inc | 2 | $30 |
Products named: deep tms, VRAYLAR, HETLIOZ, CAPLYTA, REXULTI, INGREZZA, Dyanavel XR, AUSTEDO XR.
Industry payments across NC — which companies pay providers there.
